Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI
Market Cap$661.58M
Close$
Share Statistics
| Market cap | $661.58 Million |
|---|---|
| Enterprise Value | $425.96 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.05 |
| Beta | 0.25 |
| Outstanding Shares | 143,425,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.18 |
|---|---|
| PEG | -1.47 |
| Price to Sales | 2.41 |
| Price to Book Ratio | 0.8 |
| Enterprise Value to Revenue | 1.76 |
| Enterprise Value to EBIT | -1.61 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Maravai LifeSciences Holdings Inc
3 employeesMaravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are ...